Challenging Cases in Chronic Urticaria

Allergy/ Immunology
Curriculum:
Challenging Cases in Chronic Urticaria
Credits:
1 AMA PRA Category 1 Credit(s)™
Launch Date:
December 06, 2016
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

Allergy/immunology physicians, allergy/immunology NPs and PAs, dermatology physicians, dermatology NPs and PAs

Relevant Terms:

Chronic urticaria, urticaria, CU, CIU, hives

Michael E. Manning, MD, FAAAAI, FACAAI

Michael E. Manning, MD, FAAAAI, FACAAI
President/Medical Director
Medical Research of Arizona
Allergy, Asthma & Immunology Associates, Ltd.
Scottsdale, Arizona

Michael E. Manning, MD, FAAAAI, FACAAI, is president of Allergy, Asthma and Immunology Associates, Ltd., and medical director of the clinical research division, Medical Research of Arizona.
 
Dr. Manning is a graduate of Baylor University in Waco, Texas, and he received his medical degree from the University of Texas Medical School at Houston. He completed an internship and subsequent residency in internal medicine at St. Joseph's Hospital and Medical Center in Phoenix, Arizona, and an allergy and immunology fellowship at Scripps Clinic and Research Foundation in La Jolla, California.
 
Dr. Manning has served as president of the Greater Phoenix Allergy Society, the Arizona State Allergy and Asthma Society, and the Western Society of Allergy, Asthma and Immunology. He is a fellow of the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and a member of the American Thoracic Society and the American College of Physicians.  Dr. Manning is currently on the Board of Regents of the American College of Allergy, Asthma and Immunology. 

Luz Fonacier, MD, FAAAAI, FACAAI

Luz Fonacier, MD, FAAAAI, FACAAI
Professor of Medicine, State University of New York at Stony Brook
Stony Brook, New York
Head of Allergy
Program Director of Allergy and Immunology Fellowship Program
Winthrop-University Hospital
Mineola, New York

Dr. Luz Fonacier, MD, FAAAAI, FACAAI, is the Head of Allergy in Winthrop University Hospital, a clinical campus of Stony Brook University School of Medicine, and serves as the Program Director for the Allergy and Immunology Fellowship Program. Dr. Fonacier is also a professor of medicine in SUNY at Stony Brook. She completed residencies in Dermatology and Internal Medicine, a fellowship in Allergy and Immunology in New York Hospital-Cornell Medical Center, and a fellowship in Dermal Immunology at New York University Medical Center. 
 
Dr. Fonacier serves as the Treasurer of the American College of Allergy, Asthma and Immunology (ACAAI). She chaired the Committee on Dermatologic Allergy of the ACAAI and the Food Allergy, Dermatologic, Drug and Anaphylaxis Interest Section of the American Academy of Allergy, Asthma and Immunology (AAAAI). She is the recipient of the 2014 ARTrust™ and Anjuli Seth Nayak AAAAI Lectureship, the 2012 ACAAI John P. McGovern Lectureship, the 2010 ACAAI Jean A. Chapman Memorial Lectureship, the 2009 ACAAI "Women in Allergy Award," and the 1998 Presidential Award of the Asian Pacific Association of Allergy and Clinical Immunology. Dr. Fonacier also served as president of the Long
Island Allergy Society.

Dr. Fonacier has numerous publications in textbooks and journals and continues to be a speaker and faculty in the annual national conventions of the ACAAI, AAAAI, and other national and international societies. Because of her training in dermatology, allergy, and immunology, Dr. Fonacier's special interest is the dermatologic manifestations of allergic diseases.

​Richard G. Gower, MD, FACAAI, FAAAAI, FACP

Richard G. Gower, MD, FACAAI, FAAAAI, FACP
Past Clinical Associate Professor of Medicine
University of Washington School of Medicine
Principal Investigator
Marycliff Clinical Research
Spokane, Washington

Richard G. Gower, MD, FACAAI, FAAAAI, FACP, is a Past Clinical Associate Professor of Medicine at the University of Washington School of Medicine and on the staff of Sacred Heart Medical Center in Spokane. He is past president of the American College of Allergy, Asthma and Immunology (ACAAI), and a fellow of the ACAAI, the American Academy of Allergy, Asthma and Immunology, and the American College of Physicians.
 
After receiving his medical degree from the University of Colorado School of Medicine in Denver, Dr. Gower completed a residency in internal medicine at the University of Miami Affiliated Hospitals in Miami, Florida. He then completed a fellowship in allergy/clinical immunology and vasculitis at the University of Colorado Medical Center in Denver.
 
Dr. Gower has been primary investigator in more than 150 clinical studies on the treatment of asthma, allergic rhinitis/conjunctivitis, sinusitis, atopic dermatitis, chronic urticaria, bronchitis, chronic obstructive pulmonary disease, and hereditary angioedema (HAE). Dr. Gower has presented papers at national and international meetings concerning diseases of the respiratory tract, as well as urticaria and angioedema.
 
Dr. Gower is past president of the Intermountain West Allergy Association; Western Society of Allergy, Asthma and Immunology; and Washington State Society of Internal Medicine, and he is a member of numerous professional societies. In 2013, Dr. Gower was awarded the ACAAI Distinguished Fellow Award. He is a past chair of the ACAAI Public Awareness and Education Campaign. A major goal of this national campaign is to educate the public about allergies and asthma. Dr. Gower addressed these important issues on Capitol Hill at a national level for years.
 
In recent years, Dr. Gower has been an author of several publications regarding hereditary angioedema and urticaria—including two international consensus guideline papers—and has participated in many urticaria and angioedema education sessions.
1. Formulate an appropriate diagnostic workup for symptomatology suggestive of chronic urticaria (CU), taking into account the potential differential diagnosis
2. Screen for and assess quality of life issues in patients with CU
3. Incorporate into practice evidence-based treatment options and guidelines for managing CU that maximize efficacy while minimizing adverse effects
4. Utilize the principles of patient engagement and shared decision making to implement strategies for effective management of quality of life issues in patients with CU

PHYSICIAN CONTINUING MEDICAL EDUCATION
 
Accreditation Statement
 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and RMEI Medical Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
 
Credit Designation
 
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
DISCLOSURE OF CONFLICTS OF INTEREST
 
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
 
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
  • Michael E. Manning, MD, FAAAAI, FACAAI, has affiliations with Genentech (Non-CME/CE Services); and Novartis (Contracted Research).
  • Luz Fonacier, MD, FAAAAI, FACAAI, has affiliations with Church and Dwight, Co.,Regeneron (Consulting Fees); and Genentech, Merck (Contracted Research).
  • Richard G. Gower, MD, FACAAI, FAAAAI, FACP, has affiliations with Genentech (Consulting Fees); and Genentech, Novartis (Non-CME/CE Services and Contracted Research). 
RMEI Medical Education, LLC
  • Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
  • Nora Hartley has no affiliations with commercial interests relative to the content to disclose.​
Postgraduate Institute for Medicine
 
The following PIM planners and managers, Judi Smelker-Mitchek, RN, BSN, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, and Jan Schultz, MSN, RN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
 
DISCLAIMER
 
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
 
DISCLOSURE OF UNLABELED USE
 
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
 
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 
Estimated time to complete: 1 hour
 
Medium: Internet
 
FEE INFORMATION
 
There is no fee for this educational activity.
 
COMMERCIAL SUPPORT
 
This activity is jointly provided by Postgraduate Institute for Medicine and RMEI Medical Education, LLC. This activity is supported by an independent educational grant from Novartis.
 
HOW TO RECEIVE CREDIT
 
By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Complete the activity evaluation.
Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
 
COURSE VIEWING REQUIREMENTS
Supported Browsers:
Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above